489 related articles for article (PubMed ID: 18035720)
1. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
Severina IS
Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720
[TBL] [Abstract][Full Text] [Related]
2. [Potentiation of nitric oxide-dependent activation of soluble guanylate cyclase by levomycetin, tetracycline, and oxolin].
Shchegolev AIu; Sidorova TA; Severina IS
Biomed Khim; 2009; 55(3):331-7. PubMed ID: 19663005
[TBL] [Abstract][Full Text] [Related]
3. [Nitric oxide. The role of guanylate cyclase in its physiological effects].
Severina IS
Vopr Med Khim; 2002; 48(1):4-30. PubMed ID: 12068497
[TBL] [Abstract][Full Text] [Related]
4. [YC-1-like potentiation of nitric oxide-dependent activation of soluble guanylyl cyclase by adrenochrome].
Severina IS; Piatakova NV; Shchegolev AIu; Sidorova TA
Biomed Khim; 2008; 54(6):679-86. PubMed ID: 19205427
[TBL] [Abstract][Full Text] [Related]
5. [Potentiation of NO-dependent activation of soluble guanylate cyclase by polyamines].
Severina IS; Piatakova NV; Shchegolev AIu
Biomed Khim; 2007; 53(1):44-9. PubMed ID: 17436683
[TBL] [Abstract][Full Text] [Related]
6. [Potentiation of activation of soluble guanylate cyclase by YC-1, NO-donors and increase of the synergistic effect of YC-1 on NO-dependent activation of the enzyme by 1,2,3-triazolyl-1,2,5-oxadiazole derivatives].
Severina IS; Pyatakova NV; Shchegolev AY; Rozhkov VY; Batog LV; Makhova NN
Biomed Khim; 2015; 61(6):705-11. PubMed ID: 26716741
[TBL] [Abstract][Full Text] [Related]
7. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
Severina IS
Biochemistry (Mosc); 1998 Jul; 63(7):794-801. PubMed ID: 9721331
[TBL] [Abstract][Full Text] [Related]
8. Regulation of nitric oxide-sensitive guanylyl cyclase.
Friebe A; Koesling D
Circ Res; 2003 Jul; 93(2):96-105. PubMed ID: 12881475
[TBL] [Abstract][Full Text] [Related]
9. Binding of YC-1/BAY 41-2272 to soluble guanylate cyclase: A new perspective to the mechanism of activation.
Pal B; Kitagawa T
Biochem Biophys Res Commun; 2010 Jul; 397(3):375-9. PubMed ID: 20513359
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1.
Martin NI; Derbyshire ER; Marletta MA
Bioorg Med Chem Lett; 2007 Sep; 17(17):4938-41. PubMed ID: 17587571
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of phosphodiesterase type 5 by the activator of nitric oxide-sensitive guanylyl cyclase BAY 41-2272.
Mullershausen F; Russwurm M; Friebe A; Koesling D
Circulation; 2004 Apr; 109(14):1711-3. PubMed ID: 15066950
[TBL] [Abstract][Full Text] [Related]
12. An evolutionarily conserved mechanism for sensitization of soluble guanylyl cyclase reveals extensive nitric oxide-mediated upregulation of cyclic GMP in insect brain.
Ott SR; Delago A; Elphick MR
Eur J Neurosci; 2004 Sep; 20(5):1231-44. PubMed ID: 15341595
[TBL] [Abstract][Full Text] [Related]
13. Soluble guanylyl cyclase: physiological role as an NO receptor and the potential molecular target for therapeutic application.
Nakane M
Clin Chem Lab Med; 2003 Jul; 41(7):865-70. PubMed ID: 12940510
[TBL] [Abstract][Full Text] [Related]
14. The alpha2beta1 isoform of guanylyl cyclase mediates plasma membrane localized nitric oxide signalling.
Bellingham M; Evans TJ
Cell Signal; 2007 Oct; 19(10):2183-93. PubMed ID: 17643962
[TBL] [Abstract][Full Text] [Related]
15. [Soluble guanylate cyclase in the molecular mechanism underlying the therapeutic action of drugs].
Piatakova NV; Severina IS
Biomed Khim; 2012; 58(1):32-42. PubMed ID: 22642150
[TBL] [Abstract][Full Text] [Related]
16. YC-1-like potentiation of NO-dependent activation of soluble guanylate cyclase by derivatives of protoporphyrin IX.
Severina IS; Pyatakova NV; Shchegolev AY; Ponomarev GV
Biochemistry (Mosc); 2006 Mar; 71(3):340-4. PubMed ID: 16545073
[TBL] [Abstract][Full Text] [Related]
17. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
[TBL] [Abstract][Full Text] [Related]
18. Regulation of soluble guanylyl cyclase activity by oestradiol and progesterone in the hypothalamus but not hippocampus of female rats.
Reyna-Neyra A; Sarkar G; Etgen AM
J Neuroendocrinol; 2007 Jun; 19(6):418-25. PubMed ID: 17388815
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells.
Schmidt K; Schrammel A; Koesling D; Mayer B
Mol Pharmacol; 2001 Feb; 59(2):220-4. PubMed ID: 11160856
[TBL] [Abstract][Full Text] [Related]
20. In vivo exposure to carbon monoxide causes delayed impairment of activation of soluble guanylate cyclase by nitric oxide in rat brain cortex and cerebellum.
Hernández-Viadel M; Castoldi AF; Coccini T; Manzo L; Erceg S; Felipo V
J Neurochem; 2004 Jun; 89(5):1157-65. PubMed ID: 15147508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
